Search research articles
Contact Us
Filters
Showing results (31-40 of 77) with videos related to
Page
of 8
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
July 22, 2025
From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy?
Lukas Pillong, Caroline Burgard, Florian Rosar, et al.
Diagnostics (Basel, Switzerland)
|
September 23, 2022
Multicenter Observational Study to Evaluate the Diagnostic Value of Sonography in Patients with Chronic Rhinosinusitis
Alessandro Bozzato, Christoph Arens, Maximilian Linxweiler, et al.
Frontiers in Immunology
|
May 14, 2023
Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with Dupilumab
Zeynep Danisman, Maximilian Linxweiler, Jan Philipp Kühn, et al.
Journal of Cancer Research and Clinical Oncology
|
March 22, 2018
Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations
Silke Wemmert, Maximilian Linxweiler, Cornelia Lerner, et al.
The American Journal of Pathology
|
December 27, 2011
Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer
Maximilian Linxweiler, Johannes Linxweiler, Monika Barth, et al.
Cancer Cell
|
July 7, 2023
Patterns of immune equilibrium and escape in indolent and progressing tumors
Abhinav Pandey, Maximilian Linxweiler, Fengshen Kuo, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
October 3, 2023
Dual Sec62/Ki67 immunocytochemistry of liquid-based cytological preparations represents a highly valid biomarker for non-invasive detection of head and neck squamous cell carcinomas
Jan Philipp Kühn, Stefanie Speicher, Barbara Linxweiler, et al.
Oncology Letters
|
January 25, 2019
Expression of 3q oncogene <i>SEC62</i> in atypical fibroxanthoma-immunohistochemical analysis of 41 cases and correlation with clinical, viral and histopathologic features
Cornelia S L Müller, Léa Kreie, Florian Bochen, et al.
Cancers
|
April 30, 2021
Expression of <i>SEC62</i> Oncogene in Benign, Malignant and Borderline Melanocytic Tumors-Unmasking the Wolf in Sheep's Clothing?
Cornelia S L Müller, Claudia Pföhler, Maria Wahl, et al.
BMC Cancer
|
December 6, 2013
Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells
Maximilian Linxweiler, Stefan Schorr, Nico Schäuble, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 77) with videos related to
Sort By:
Page
of 8
European Journal of Nuclear Medicine and Molecular Imaging
|
July 22, 2025
From bench to bedside, blade, and back: FAP expression in juvenile angiofibroma. Potential implications for FAPI-PET/CT imaging and targeted therapy?
Lukas Pillong, Caroline Burgard, Florian Rosar, et al.
Diagnostics (Basel, Switzerland)
|
September 23, 2022
Multicenter Observational Study to Evaluate the Diagnostic Value of Sonography in Patients with Chronic Rhinosinusitis
Alessandro Bozzato, Christoph Arens, Maximilian Linxweiler, et al.
Frontiers in Immunology
|
May 14, 2023
Differential nasal swab cytology represents a valuable tool for therapy monitoring but not prediction of therapy response in chronic rhinosinusitis with nasal polyps treated with Dupilumab
Zeynep Danisman, Maximilian Linxweiler, Jan Philipp Kühn, et al.
Journal of Cancer Research and Clinical Oncology
|
March 22, 2018
Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations
Silke Wemmert, Maximilian Linxweiler, Cornelia Lerner, et al.
The American Journal of Pathology
|
December 27, 2011
Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer
Maximilian Linxweiler, Johannes Linxweiler, Monika Barth, et al.
Cancer Cell
|
July 7, 2023
Patterns of immune equilibrium and escape in indolent and progressing tumors
Abhinav Pandey, Maximilian Linxweiler, Fengshen Kuo, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology
|
October 3, 2023
Dual Sec62/Ki67 immunocytochemistry of liquid-based cytological preparations represents a highly valid biomarker for non-invasive detection of head and neck squamous cell carcinomas
Jan Philipp Kühn, Stefanie Speicher, Barbara Linxweiler, et al.
Oncology Letters
|
January 25, 2019
Expression of 3q oncogene <i>SEC62</i> in atypical fibroxanthoma-immunohistochemical analysis of 41 cases and correlation with clinical, viral and histopathologic features
Cornelia S L Müller, Léa Kreie, Florian Bochen, et al.
Cancers
|
April 30, 2021
Expression of <i>SEC62</i> Oncogene in Benign, Malignant and Borderline Melanocytic Tumors-Unmasking the Wolf in Sheep's Clothing?
Cornelia S L Müller, Claudia Pföhler, Maria Wahl, et al.
BMC Cancer
|
December 6, 2013
Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells
Maximilian Linxweiler, Stefan Schorr, Nico Schäuble, et al.
Page
of 8